About this trial
The goal of this feasibility study is to test whether a new approach that combines real-time symptom tracking (Ecological Momentary Assessment) with machine learning can help people recovering from a stroke to better manage depression, thinking difficulties, and daily functioning. The main questions it aims to answer are:
Is this combined approach practical and acceptable for post-stroke survivors? Does the program improve mood, cognitive function, or functional ability to carry out daily activities?
Participants will:
Use a smartphone app called RehabCare Companion for a period of time Answer brief daily surveys about their mood, thoughts, and activities for one week Receive personalized self-care suggestions generated by machine learning based on their responses Complete assessments of depression, cognition, and functioning before and after the program Take part in a group interview to share their experiences
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adults aged 18 years or older
having a confirmed diagnosis of stroke
having sufficient proficiency in Cantonese to understand and respond to the assessments and prompts
having a Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) score of 18 or higher
Disqualifiers
they have moderate to severe cognitive impairment (a HK-MoCA score of 17 or lower)
they have active psychiatric disorders other than depression (e.g., schizophrenia, bipolar disorder)
they have a terminal illness or prognosis that suggests a limited life expectancy
they have conditions that compromise their self-care ability (i.e., bedbound).
Trial design
Single group
Treatments tested in this trial
Ecological Momentary Assessment based Self-management Program
BehavioralThe research team collects participants' EMA data (ie., depression, cognitive function, daily activity, and contextual data) from participants for 7-day and analyze the data by machine learning in the first phase, while provide real-time, individualized, self-care messages to the participants via a personalized self-care AI app in the second phase.
Treatment groups
Trial outcomes
Primary outcomes
Feasibility of the study: acceptance
The acceptance of participants to the program will be measured by recruitment rate, attrition rate, and retention rate.
Feasibility of the study: adherence
The adherence of the participants will be evaluated by using the percentage of completed EMA assessments and the frequency of app usage.
Feasibility of the study: experience of the participants in using the app
Participants' experience will be assessed through individual interviews.
Secondary outcomes
Preliminary effectiveness: depression Levels
Beck Depression Inventory (BDI) will be used to assess the depression levels of post-stroke patients.
Preliminary effectiveness: cognitive function
Cognitive function will be screened using Montreal Cognitive Assessment Hong Kong version (HK-MoCA).
Preliminary effectiveness: disability and functioning
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a widely used instrument for assessing disability and functioning in individuals.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.